Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] NLMUID: 8707234"" wg kryterium: JN


Tytuł :
Higher concentrations of cytokine blockers are needed to obtain small bowel mucosal healing during maintenance therapy in Crohn's disease.
Autorzy :
Takenaka K; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.; Endoscopic Unit, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
Kawamoto A; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Hibiya S; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.; Endoscopic Unit, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
Suzuki K; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.; Endoscopic Unit, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
Fujii T; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Motobayashi M; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Shimizu H; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Nagahori M; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Saito E; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Okamoto R; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.
Watanabe M; TMDU Advanced Research Institute, Tokyo Medical and Dental University, Tokyo, Japan.
Ohtsuka K; Endoscopic Unit, Tokyo Medical and Dental University Hospital, Tokyo, Japan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 29. Date of Electronic Publication: 2021 Jul 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Systematic review with meta-analysis: dietary intake in adults with inflammatory bowel disease.
Autorzy :
Lambert K; School of Medicine, Faculty of Science, Medicine and Health; Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.
Pappas D; School of Medicine, Faculty of Science, Medicine and Health; Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.
Miglioretto C; School of Medicine, Faculty of Science, Medicine and Health; Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.
Javadpour A; School of Medicine, Faculty of Science, Medicine and Health; Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.
Reveley H; School of Medicine, Faculty of Science, Medicine and Health; Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.
Frank L; School of Medicine, Faculty of Science, Medicine and Health; Illawarra Health and Medical Research Institute, University of Wollongong, Wollongong, New South Wales, Australia.
Grimm MC; University of New South Wales, Sydney, New South Wales, Australia.
Samocha-Bonet D; Dorit Samocha-Bonet, Garvan Institute of Medical Research and University of New South Wales, Sydney, New South Wales, Australia.
Hold GL; University of New South Wales, Sydney, New South Wales, Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 29. Date of Electronic Publication: 2021 Jul 29.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Systematic review: duodenogastroesophageal (biliary) reflux prevalence, symptoms, oesophageal lesions and treatment.
Autorzy :
Basnayake C; Department of Chronic Diseases, Metabolism and Ageing (ChroMetA), Translational Research Center for Gastrointestinal Disorders (TARGID), Katholieke Universiteit Leuven, Leuven, Belgium.; St Vincent's Hospital & University of Melbourne, Melbourne, VIC, Australia.
Geeraerts A; Department of Chronic Diseases, Metabolism and Ageing (ChroMetA), Translational Research Center for Gastrointestinal Disorders (TARGID), Katholieke Universiteit Leuven, Leuven, Belgium.
Pauwels A; Department of Chronic Diseases, Metabolism and Ageing (ChroMetA), Translational Research Center for Gastrointestinal Disorders (TARGID), Katholieke Universiteit Leuven, Leuven, Belgium.
Koek G; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.
Vaezi M; Vanderbilt University Medical Center, Nashville, TN, USA.
Vanuytsel T; Department of Chronic Diseases, Metabolism and Ageing (ChroMetA), Translational Research Center for Gastrointestinal Disorders (TARGID), Katholieke Universiteit Leuven, Leuven, Belgium.
Tack J; Department of Chronic Diseases, Metabolism and Ageing (ChroMetA), Translational Research Center for Gastrointestinal Disorders (TARGID), Katholieke Universiteit Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 27. Date of Electronic Publication: 2021 Jul 27.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology.
Autorzy :
Pierre N; Laboratory of Translational Gastroenterology, GIGA-Institute, University of Liège, Liège, Belgium.
Salée C; Laboratory of Translational Gastroenterology, GIGA-Institute, University of Liège, Liège, Belgium.
Vieujean S; Laboratory of Translational Gastroenterology, GIGA-Institute, University of Liège, Liège, Belgium.; Hepato-Gastroenterology and Digestive Oncology Department, Liège University Hospital, Liège, Belgium.
Bequet E; Laboratory of Translational Gastroenterology, GIGA-Institute, University of Liège, Liège, Belgium.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Liège University Hospital, Liège, Belgium.
Merli AM; Laboratory of Translational Gastroenterology, GIGA-Institute, University of Liège, Liège, Belgium.
Siegmund B; Division of Gastroenterology, Infectiology and Rheumatology, Medical Department, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
Meuwis MA; Laboratory of Translational Gastroenterology, GIGA-Institute, University of Liège, Liège, Belgium.; Hepato-Gastroenterology and Digestive Oncology Department, Liège University Hospital, Liège, Belgium.
Louis E; Laboratory of Translational Gastroenterology, GIGA-Institute, University of Liège, Liège, Belgium.; Hepato-Gastroenterology and Digestive Oncology Department, Liège University Hospital, Liège, Belgium.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 23. Date of Electronic Publication: 2021 Jul 23.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Effectiveness and safety of ustekinumab maintenance therapy in 103 patients with ulcerative colitis: a GETAID cohort study.
Autorzy :
Fumery M; Amiens, France.
Filippi J; Nice, France.
Abitbol V; Paris, France.
Biron A; Reims, France.
Laharie D; Bordeaux, France.
Serrero M; Marseille, France.
Altwegg R; Montpellier, France.
Bouhnik Y; Clichy, France.
Peyrin-Biroulet L; Nancy, France.
Gilletta C; Toulouse, France.
Roblin X; Saint-Etienne, France.
Pineton de Chambrun G; Montpellier, France.
Vuitton L; Besançon, France.
Bourrier A; Paris, France.
Nancey S; Lyon, France.
Gornet JM; Paris, France.
Nahon S; Montfermeil, France.
Bouguen G; Rennes, France.
Viennot S; Caen, France.
Nachury M; Lille, France.
Amiot A; Creteil, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 23. Date of Electronic Publication: 2021 Jul 23.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Acute gastrointestinal bleeding: proposed study outcomes for new randomised controlled trials.
Autorzy :
Jensen DM; Los Angeles, CA, USA.
Barkun A; Montréal, QC, Canada.
Cave D; Worcester, MA, USA.
Gralnek IM; Haifa, Israel.; Afula, Israel.
Jutabha R; Los Angeles, CA, USA.
Laine L; New Haven, CT, USA.; West Haven, CT, USA.
Lau JYW; Shatin, Hong Kong.
Saltzman JR; Boston, MA, USA.
Soetikno R; San Francisco, CA, USA.
Sung JJY; Singapore.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 20. Date of Electronic Publication: 2021 Jul 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus-related infection before and after liver transplantation.
Autorzy :
Duvoux C; Créteil, France.
Belli LS; Milan, Italy.
Fung J; Hong Kong, China.
Angelico M; Rome, Italy.
Buti M; Barcelona, Spain.
Coilly A; Villejuif, France.
Cortesi P; Milan, Italy.
Durand F; Clichy, France.
Féray C; Villejuif, France.
Fondevila C; Barcelona, Spain.
Lebray P; Paris, France.
Martini S; Turin, Italy.
Nevens F; Leuven, Belgium.
Polak WG; Rotterdam, Netherlands.
Rizzetto M; Turin, Italy.
Volpes R; Palermo, Italy.
Zoulim F; Lyon, France.
Samuel D; Villejuif, France.
Berenguer M; Valencia, Spain.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 19. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Predictors of drug survival: A cohort study comparing anti-tumour necrosis factor agents using the Swedish inflammatory bowel disease quality register.
Autorzy :
Visuri I; Örebro, Sweden.
Eriksson C; Örebro, Sweden.; Stockholm, Sweden.
Olén O; Stockholm, Sweden.
Cao Y; Örebro, Sweden.
Mårdberg E; Örebro, Sweden.
Grip O; Malmö, Sweden.
Gustavsson A; Karlstad, Sweden.
Hjortswang H; Linköping, Sweden.
Karling P; Umeå, Sweden.
Montgomery S; Örebro, Sweden.; Stockholm, Sweden.
Myrelid P; Linköping, Sweden.
Ludvigsson JF; Örebro, Sweden.; Stockholm, Sweden.
Halfvarson J; Örebro, Sweden.
Pokaż więcej
Corporate Authors :
SWIBREG study group
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 19. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Immunologic markers and risk of hepatocellular carcinoma in hepatitis B virus- and hepatitis C virus-infected individuals.
Autorzy :
Koshiol J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Argirion I; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Liu Z; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Kim Lam T; Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
O'Brien TR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Yu K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
McGlynn KA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Petrick JL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; School of Medicine, Slone Epidemiology Center, Boston University, Boston, MA, USA.
Pinto L; HPV Immunology Laboratory, Frederick National Laboratory for Cancer Research, Leidos, Biomedical Research, Inc, Frederick, MD, USA.
Chen CJ; Genomics Research Center, Academia Sinica, Taipei, Taiwan.; Graduate Institute of Epidemiology and Preventative Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
Hildesheim A; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Pfeiffer RM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Lee MH; National Yang Ming Chiao Tung University, Taipei, Taiwan.
Yang HI; Genomics Research Center, Academia Sinica, Taipei, Taiwan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 19. Date of Electronic Publication: 2021 Jul 19.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Presence of high-risk HLA genotype is the most important individual risk factor for coeliac disease among at-risk relatives.
Autorzy :
Paavola S; Faculty of Medicine and Health Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.
Lindfors K; Faculty of Medicine and Health Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.
Kivelä L; Faculty of Medicine and Health Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.
Cerqueira J; Faculty of Medicine and Health Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.
Huhtala H; Faculty of Social Sciences, University of Tampere, Tampere, Finland.
Saavalainen P; Translational Immunology Research Program, and Department of Medical and Clinical Genetics, University of Helsinki, Helsinki, Finland.
Tauschi R; Faculty of Medicine and Health Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.
Kaukinen K; Faculty of Medicine and Health Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.
Kurppa K; Faculty of Medicine and Health Technology, University of Tampere and Tampere University Hospital, Tampere, Finland.; The University Consortium of Seinäjoki, Seinäjoki, Finland.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 18. Date of Electronic Publication: 2021 Jul 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Systematic review with meta-analysis: effects of implementing a nutrition support team for in-hospital parenteral nutrition.
Autorzy :
Eriksen MK; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Crooks B; Intestinal Failure Unit, Salford Royal NHS Foundation Trust, Salford, UK.
Baunwall SMD; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Rud CL; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Lal S; Intestinal Failure Unit, Salford Royal NHS Foundation Trust, Salford, UK.
Hvas CL; Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 18. Date of Electronic Publication: 2021 Jul 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Serum hepatitis B virus RNA level is associated with biochemical relapse in patients with chronic hepatitis B infection who discontinue nucleos(t)ide analogue treatment.
Autorzy :
Xia M; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Chi H; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
Wu Y; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Hansen BE; Toronto Centre of Liver Disease, University Health Network, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.
Li Z; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Liu S; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Liao G; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhang X; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Zhou B; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Hou J; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Sun J; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Janssen HLA; Toronto Centre of Liver Disease, University Health Network, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.
Peng J; State Key Laboratory of Organ Failure Research, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 18. Date of Electronic Publication: 2021 Jul 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Systematic review with meta-analysis: neoplasia detection rate and post-endoscopy Barrett's neoplasia in Barrett's oesophagus.
Autorzy :
Hamade N; Division of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN, USA.
Kamboj AK; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Krishnamoorthi R; Division of Gastroenterology and Hepatology, Virginia Mason Medical Centre, Seattle, WA, USA.
Singh S; Division of Gastroenterology and Hepatology, University of California San Diego, San Diego, CA, USA.
Hassett LC; Mayo Clinic, Rochester, MN, USA.
Katzka DA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Kahi CJ; Division of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN, USA.
Fatima H; Division of Gastroenterology and Hepatology, Indiana University, Indianapolis, IN, USA.
Iyer PG; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 18. Date of Electronic Publication: 2021 Jul 18.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Systematic review: hepatitis C viraemic allografts to hepatitis C-negative recipients in solid organ transplantation.
Autorzy :
Raasikh T; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Jamali T; Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Flores A; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center, Houston, TX, USA.; Section of Gastroenterology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.
Cotton RT; Division of Abdominal Transplantation, Department of Surgery, Baylor College of Medicine, Houston, TX, USA.
Ramanathan V; Division of Nephrology and Solid-Organ Transplantation, Michael E. DeBakey VA Medical Center, Houston, TX, USA.
Tan HP; Surgery, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, VA Pittsburgh Medical Center, Pittsburgh, PA, USA.
Hernaez R; Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center, Houston, TX, USA.; Section of Gastroenterology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA.; Center for Innovations in Quality, Effectiveness and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 15. Date of Electronic Publication: 2021 Jul 15.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
PRO-C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol-related liver disease.
Autorzy :
Madsen BS; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense C, Denmark.; OPEN, Odense Patient Data Exploratory Network, Odense University Hospital, Odense C, Denmark.
Thiele M; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense C, Denmark.; OPEN, Odense Patient Data Exploratory Network, Odense University Hospital, Odense C, Denmark.
Detlefsen S; Department of Pathology, Odense University Hospital, Odense C, Denmark.; Institute of Clinical Research, University of Southern Denmark, Odense C, Denmark.
Kjaergaard M; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense C, Denmark.; OPEN, Odense Patient Data Exploratory Network, Odense University Hospital, Odense C, Denmark.
Møller LS; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense C, Denmark.; OPEN, Odense Patient Data Exploratory Network, Odense University Hospital, Odense C, Denmark.
Trebicka J; Institute of Clinical Research, University of Southern Denmark, Odense C, Denmark.; Department of Internal Medicine I, University Clinic Frankfurt, Frankfurt, Germany.; European Foundation for the Study of Chronic Liver Failure - EF Clif, Barcelona, Spain.; Institute for Bioengineering of Catalonia, Barcelona, Spain.
Nielsen MJ; Nordic Bioscience Biomarkers and Research A/S, Herlev, Denmark.
Gudmann NS; Nordic Bioscience Biomarkers and Research A/S, Herlev, Denmark.
Leeming DJ; Nordic Bioscience Biomarkers and Research A/S, Herlev, Denmark.
Karsdal MA; Nordic Bioscience Biomarkers and Research A/S, Herlev, Denmark.
Krag A; Department of Gastroenterology and Hepatology, Odense University Hospital, Odense C, Denmark.; OPEN, Odense Patient Data Exploratory Network, Odense University Hospital, Odense C, Denmark.
Pokaż więcej
Corporate Authors :
GALAXY consortium
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 12. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies.
Autorzy :
Kim YD; Department of Internal Medicine, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Wang J; Department of Internal Medicine, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Shibli F; Division of Gastroenterology and Hepatology, The Oesophageal and Swallowing Center, Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH, USA.
Poels KE; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Ganocy SJ; Data Management and Statistical Analysis Unit, Mood Disorders Program, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH, USA.
Fass R; Division of Gastroenterology and Hepatology, The Oesophageal and Swallowing Center, Case Western Reserve University, MetroHealth Medical Center, Cleveland, OH, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 12. Date of Electronic Publication: 2021 Jul 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics.
Autorzy :
Singal AK; Department of Internal Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, SD, USA.; Division of Gastroenterology and Hepatology, Avera Transplant Institute, Sioux Falls, SD, USA.
Arsalan A; Department of Internal Medicine, University of South Dakota Sanford School of Medicine, Sioux Falls, SD, USA.
Dunn W; Division of Gastroenterology and Hepatology, Kansas University Medical Center, Kansas City, KS, USA.
Arab JP; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
Wong RJ; Division of Gastroenterology and Hepatology, Palo Alto VA Medical Center, Stanford University, Stanford, CA, USA.
Kuo YF; Department of Biostatistics, University of Texas Medical Branch, Galveston, TX, USA.
Kamath PS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Shah VH; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 11. Date of Electronic Publication: 2021 Jul 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma.
Autorzy :
Tan RZH; St Vincent's Clinical School, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.
Lockart I; St Vincent's Clinical School, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.; St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW, Australia.; Department of Gastroenterology and Hepatology, St Vincent's Hospital, Sydney, NSW, Australia.
Abdel Shaheed C; School of Public Health, The University of Sydney, Sydney, NSW, Australia.
Danta M; St Vincent's Clinical School, Faculty of Medicine and Health, UNSW, Sydney, NSW, Australia.; St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW, Australia.; Department of Gastroenterology and Hepatology, St Vincent's Hospital, Sydney, NSW, Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 11. Date of Electronic Publication: 2021 Jul 11.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Sleep disturbances in the irritable bowel syndrome and functional dyspepsia are independent of psychological distress: a population-based study of 1322 Australians.
Autorzy :
Koloski NA; College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.; Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.; Faculty of Health and Behavioural Sciences, University of Queensland, Herston, QLD, Australia.
Jones M; Department of Psychology, Macquarie University, Sydney, NSW, Australia.
Walker MM; School of Medicine and Public Health, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Keely S; School of Biomedical Sciences and Pharmacy, College of Health Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Holtmann G; Department of Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.; Faculty of Medicine, University of Queensland, St. Lucia, QLD, Australia.
Talley NJ; College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 11. Date of Electronic Publication: 2021 Jul 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Continued 5ASA use after initiation of anti-TNF or immunomodulator confers no benefit in IBD: a population-based study.
Autorzy :
Bernstein CN; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.; University of Manitoba IBD Clinical and Research Centre, Winnipeg, MB, Canada.
Tenakoon A; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.; University of Manitoba IBD Clinical and Research Centre, Winnipeg, MB, Canada.
Singh H; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.; University of Manitoba IBD Clinical and Research Centre, Winnipeg, MB, Canada.
Targownik LE; Division of Gastroenterology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 11. Date of Electronic Publication: 2021 Jul 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Review article: The aetiology of fatigue in inflammatory bowel disease and potential therapeutic management strategies.
Autorzy :
McGing JJ; School of Medicine, University of Nottingham, Nottingham, UK.; Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, UK.
Radford SJ; School of Medicine, University of Nottingham, Nottingham, UK.; National Institute of Health Research Nottingham Biomedical Research Centre (NIHR), Nottingham University Hospitals and University of Nottingham, Nottingham, UK.
Francis ST; Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, UK.; National Institute of Health Research Nottingham Biomedical Research Centre (NIHR), Nottingham University Hospitals and University of Nottingham, Nottingham, UK.
Serres S; School of Life Sciences, University of Nottingham, Nottingham, UK.
Greenhaff PL; National Institute of Health Research Nottingham Biomedical Research Centre (NIHR), Nottingham University Hospitals and University of Nottingham, Nottingham, UK.; MRC Versus Arthritis Centre for Musculoskeletal Ageing Research, National Institute for Health Research (NIHR), Nottingham Biomedical Research Centre, School of Life Sciences, University of Nottingham, Nottingham, UK.
Moran GW; School of Medicine, University of Nottingham, Nottingham, UK.; National Institute of Health Research Nottingham Biomedical Research Centre (NIHR), Nottingham University Hospitals and University of Nottingham, Nottingham, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 06. Date of Electronic Publication: 2021 Jul 06.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Randomised clinical trial: comparison of tegoprazan and placebo in non-erosive reflux disease.
Autorzy :
Kim SH; Seoul, South Korea.
Cho KB; Daegu, South Korea.
Chun HJ; Seoul, South Korea.
Lee SW; Ansan, South Korea.
Kwon JG; Daegu, South Korea.
Lee DH; Seongnam, South Korea.
Kim SG; Seoul, South Korea.
Jung HY; Seoul, South Korea.
Kim JW; Seoul, South Korea.
Lee JS; Seoul, South Korea.
Park H; Seoul, South Korea.
Choi SC; Iksan, South Korea.
Jee SR; Busan, South Korea.
Kim HS; Kwangju, South Korea.
Ko KH; Seongnam, South Korea.
Park SJ; Busan, South Korea.
Lee YC; Seoul, South Korea.
Park SH; Seoul, South Korea.
Kim AR; Seoul, South Korea.
Kim EJ; Seoul, South Korea.
Park HW; Seoul, South Korea.
Kim BT; Seoul, South Korea.
Song GS; Seoul, South Korea.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 06. Date of Electronic Publication: 2021 Jul 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Nonselective beta-blockers are associated with a lower risk of hepatocellular carcinoma among cirrhotic patients in the United States.
Autorzy :
Wijarnpreecha K; Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA.
Li F; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Xiang Y; Peng Cheng Laboratory, Shenzhen, China.
Xu X; Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Zhu C; Department of Epidemiology, Human Genetics and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Maroufy V; Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Wang Q; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Tao W; Department of Biostatistics and Data Science, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Dang Y; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Pham HA; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Zhou Y; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Li J; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Zhang X; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Xu H; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Taner CB; Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA.
Yang L; Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA.
Tao C; School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 05. Date of Electronic Publication: 2021 Jul 05.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
An observational study of switching infliximab biosimilar: no adverse impact on inflammatory bowel disease control or drug levels with first or second switch.
Autorzy :
Luber RP; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
O'Neill R; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Singh S; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Sharma E; Department of Pharmacy, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Cunningham G; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Honap S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Meade S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Ray S; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Anderson SH; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Mawdsley J; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Sanderson JD; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Samaan MA; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Arkir Z; Viapath Analytics, Guy's & St Thomas' NHS Foundation Trust, London, UK.
Irving PM; Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.; School of Immunology and Microbial Sciences, King's College London, London, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 05. Date of Electronic Publication: 2021 Jul 05.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Review article: time to revisit Child-Pugh score as the basis for predicting drug clearance in hepatic impairment.
Autorzy :
El-Khateeb E; Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK.; Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University, Tanta, Egypt.
Darwich AS; Logistics and Informatics in Health Care, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), KTH Royal Institute of Technology, Stockholm, Sweden.
Achour B; Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK.
Athwal V; Wellcome Centre for Cell-Matrix Research, Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK.; Research and Innovation Division, Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
Rostami-Hodjegan A; Centre for Applied Pharmacokinetic Research, University of Manchester, Manchester, UK.; Certara UK Ltd. (Simcyp Division), Sheffield, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 04. Date of Electronic Publication: 2021 Jul 04.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Decreased secondary faecal bile acids in children with ulcerative colitis and Clostridioides difficile infection.
Autorzy :
Rotondo-Trivette S; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Wang B; Quantitative and Computational Biology Program, Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA.; School of Mathematics, Shandong University, Jinan, China.
Gayer C; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Children's Hospital of Los Angeles, Los Angeles, CA, USA.
Parsana R; Children's Hospital of Los Angeles, Los Angeles, CA, USA.
Luan Y; School of Mathematics, Shandong University, Jinan, China.
Sun F; Quantitative and Computational Biology Program, Department of Biological Sciences, University of Southern California, Los Angeles, CA, USA.
Michail S; Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Children's Hospital of Los Angeles, Los Angeles, CA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul 04. Date of Electronic Publication: 2021 Jul 04.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Editorial: is there a 'precursor' HCC lesion and can it be detected by hepatobiliary contrast-enhanced magnetic resonance imaging? Authors' reply.
Autorzy :
Toyoda H; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Yasuda S; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Shiota S; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 204-205.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: on the road towards treatment of gastroparesis-accelerating but do we get closer?
Autorzy :
Wuestenberghs F; Physiology Department, INSERM 1073-CIC/CRB 1404, CHU de Rouen, Normandy University, Rouen, France.; CHU UCL Namur, Department of Gastroenterology and Hepatology, Université catholique de Louvain, Yvoir, Belgium.
Gourcerol G; Physiology Department, INSERM 1073-CIC/CRB 1404, CHU de Rouen, Normandy University, Rouen, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 183-184.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: tissue findings fail to predict disease activity or prognosis in microscopic colitis-an opportunity to look at the molecular level-authors' reply.
Autorzy :
Olsen LM; Roskilde, Denmark.
Engel PJH; Roskilde, Denmark.
Goudkade D; Geleen, The Netherlands.
Villanacci V; Brescia, Italy.
Thagaard J; Hoersholm, Denmark.; Lyngby, Denmark.
Walbech JS; Køge, Denmark.
Bohr J; Örebro, Sweden.
Kupcinskas J; Kaunas, Lithuania.
Verhaegh B; Maastricht, The Netherlands.
Münch A; Linköping, Sweden.
Guagnozzi D; Barcelona, Spain.
Fernández-Bañares F; Barcelona, Spain.
Munck LK; Køge, Denmark.; Copenhagen, Denmark.
Fiehn AK; Roskilde, Denmark.; Køge, Denmark.; Copenhagen, Denmark.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 194-195.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: a long way to go before precision medicine.
Autorzy :
Amiot A; Department of Gastroenterology, Henri Mondor Hospital, APHP, EA7375, Paris Est-Créteil Univeristy (UPEC), Creteil, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 187.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: impact of body mass index on clinical outcomes in patients with ulcerative colitis treated with tofacitinib.
Autorzy :
Tassone D; Department of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, Vic., Australia.
Singh S; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.
Sheng Ding N; Department of Gastroenterology, St Vincent's Hospital Melbourne, Fitzroy, Vic., Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 206-207.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: recognising the efficacy of licensed drug therapies for IBS on bloating-a step in the right direction for targeted treatment?
Autorzy :
Vasant DH; Neurogastroenterology Unit, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK.; Division of Diabetes, Endocrinology and Gastroenterology, University of Manchester, Manchester, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 196-197.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: finding the ideal prokinetic for gastroparesis-we are not there yet.
Autorzy :
Mahadeva S; Division of Gastroenterology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 210-211.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-a realm for non-invasive testing. Authors' reply.
Autorzy :
Park JG; Division of Gastroenterology and Hepatology, Department of Medicine, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.; Department of Internal Medicine, College of Medicine, Yeungnam University, Daegu, South Korea.
Jung J; Division of Gastroenterology and Hepatology, Department of Medicine, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.
Loomba R; Division of Gastroenterology and Hepatology, Department of Medicine, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.; Department of Family Medicine and Public Health, University of California at San Diego, La Jolla, CA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 216.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating-a step in the right direction for targeted treatment? Authors' reply.
Autorzy :
Nelson AD; Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Black CJ; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Houghton LA; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Lugo-Fagundo NS; Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
Lacy BE; Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Ford AC; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 198-199.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: post-reflux swallow-induced peristaltic wave in eosinophilic oesophagitis-more questions than answers? Authors' reply.
Autorzy :
Frazzoni M; Digestive Pathophysiology Unit and Digestive Endoscopy Unit, Baggiovara Hospital, Modena, Italy.
Frazzoni L; Gastroenterology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
de Bortoli N; Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy.
Savarino E; Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 190-191.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: tissue findings fail to predict disease activity or prognosis in microscopic colitis: an opportunity to look at the molecular level.
Autorzy :
Lucendo AJ; Department of Gastroenterology, Hospital General de Tomelloso, Tomelloso, Spain.; Instituto de Investigación Sanitaria Princesa, Madrid, Spain.; Centro de Investigación Biomédica en Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 192-193.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: testing novel interventions for coeliac disease-which outcomes matter?
Autorzy :
Wolf RL; Program in Nutrition, Department of Health and Behavioral Studies, Teachers College, Columbia University, New York City, NY, USA.
Lebwohl B; Department of Medicine, Celiac Disease Center, Columbia University, New York City, NY, USA.; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York City, NY, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 200-201.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Letter: coronary atherosclerosis in patients with significant hepatic fibrosis in non-alcoholic fatty liver disease-the role for non-invasive testing.
Autorzy :
Emrich T; Division of Cardiovascular Imaging, Department of Radiology and Radiological Science, Medical University of South Carolina, Charleston, SC, USA.; Department of Radiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Rhine Main, Mainz, Germany.
Schattenberg JM; Department of Internal Medicine I, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.; Metabolic Liver Research Program, University Medical Center of the Johannes Gutenberg-University, Mainz, Germany.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 214-215.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Editorial: finding the ideal prokinetic for gastroparesis-we are not there yet. Authors' reply.
Autorzy :
Camilleri M; Clinical Enteric Neuroscience Translational and Epidemiological Research (CENTER), Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Kuo B; Harvard School of Medicine, Boston, MA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 212-213.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: is there a 'precursor' HCC lesion and can it be detected by hepatobiliary contrast-enhanced magnetic resonance imaging?
Autorzy :
Vutien P; Division of Gastroenterology and Hepatology, University of Washington, Seattle, WA, USA.; Department of Medicine Veterans Affairs Puget Sound Healthcare System, University of Washington, Seattle, WA, USA.
Ioannou GN; Division of Gastroenterology and Hepatology, University of Washington, Seattle, WA, USA.; Department of Medicine Veterans Affairs Puget Sound Healthcare System, University of Washington, Seattle, WA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 202-203.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Letter: safety of immune checkpoint inhibitors in patients with pre-established microscopic colitis-a single-centre experience.
Autorzy :
Fredrick TW; Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Braga Neto MB; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Ramos GP; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Kane S; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Pardi DS; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Raffals LE; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 217-218.
Typ publikacji :
Letter
Opinia redakcyjna
Tytuł :
Editorial: post-reflux swallow-induced peristaltic wave in eosinophilic oesophagitis-more questions than answers?
Autorzy :
Rogers BD; Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA.; Division of Gastroenterology, Hepatology, and Nutrition, University of Louisville School of Medicine, Louisville, KY, USA.
Gyawali CP; Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 188-189.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: on the road towards treatment of gastroparesis-accelerating, but do we get closer? Authors' reply.
Autorzy :
Kuo B; Massachusetts General Hospital, Boston, MA, USA.
Barnes CN; Theravance Biopharma US, Inc., South San Francisco, CA, USA.
Nguyen DD; Theravance Biopharma US, Inc., South San Francisco, CA, USA.
Shaywitz D; Theravance Biopharma US, Inc., South San Francisco, CA, USA.
Grimaldi M; Alfasigma S.p.A., Bologna, Italy.
Renzulli C; Alfasigma S.p.A., Bologna, Italy.
Canafax D; Theravance Biopharma US, Inc., South San Francisco, CA, USA.
Parkman HP; Temple University School of Medicine, Philadelphia, PA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 185-186.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Editorial: IBD medications during the COVID-19 pandemic-are they safe to use?
Autorzy :
Fan D; Department of Gastroenterology, Christchurch Hospital, Christchurch, New Zealand.
Gearry RB; Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 208-209.
Typ publikacji :
Editorial; Comment
MeSH Terms :
COVID-19*
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/epidemiology
Humans ; Pandemics ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Non-steroidal anti-inflammatory drugs, polygenic risk score and colorectal cancer risk.
Autorzy :
Chen X; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Guo F; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.
Hoffmeister M; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Chang-Claude J; Unit of Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Genetic Tumor Epidemiology Group, University Medical Center Hamburg-Eppendorf, University Cancer Center Hamburg, Hamburg, Germany.
Brenner H; Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Preventive Oncology, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 167-175. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Systematic review and network meta-analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation.
Autorzy :
Nelson AD; Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Black CJ; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Houghton LA; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Lugo-Fagundo NS; Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
Lacy BE; Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Ford AC; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 98-108. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Editorial: tobacco use in functional dyspepsia-another smoking gun?
Autorzy :
Woo MMK; Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Andrews CN; Division of Gastroenterology and Hepatology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 78.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Dyspepsia*/epidemiology
Dyspepsia*/etiology
Gastritis*
Irritable Bowel Syndrome*
Humans ; Tobacco Use
Opinia redakcyjna
Tytuł :
Efficacy of ginger as antiemetic in children with acute gastroenteritis: a randomised controlled trial.
Autorzy :
Nocerino R; Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.; CEINGE Advanced Biotechnologies, University of Naples Federico II, Naples, Italy.
Cecere G; Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.
Micillo M; Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.
De Marco G; Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.
Ferri P; Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.
Russo M; Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.
Bedogni G; CEINGE Advanced Biotechnologies, University of Naples Federico II, Naples, Italy.; Clinical Epidemiology Unit, Liver Research Center, Basovizza, Trieste, Italy.
Berni Canani R; Department of Translational Medical Science, University of Naples Federico II, Naples, Italy.; CEINGE Advanced Biotechnologies, University of Naples Federico II, Naples, Italy.; European Laboratory for the Investigation of Food-induced Diseases, University of Naples Federico II, Naples, Italy.; Task Force on Microbiome Studies, University of Naples Federico II, Naples, Italy.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 24-31. Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antiemetics*/therapeutic use
Gastroenteritis*/complications
Gastroenteritis*/drug therapy
Ginger*
Child ; Double-Blind Method ; Humans ; Nausea ; Treatment Outcome ; Vomiting/drug therapy ; Vomiting/prevention & control
Czasopismo naukowe
Tytuł :
Editorial: safety of thiopurines in pregnancy-considering the mother, foetus and newborn.
Autorzy :
Weisshof R; Department of Gastroenterology, Rambam Healthcare Campus, Haifa, Israel.
Chowers Y; Department of Gastroenterology, Rambam Healthcare Campus, Haifa, Israel.; Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.
Kurnik D; Rappaport Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.; Section of Clinical Pharmacology and Toxicology, Rambam Healthcare Campus, Haifa, Israel.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 88-89.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Inflammatory Bowel Diseases*
Mothers*
Female ; Fetus ; Humans ; Infant, Newborn ; Kinetics ; Pregnancy
Opinia redakcyjna
Tytuł :
Durable virological response and functional cure of chronic hepatitis D after long-term peginterferon therapy.
Autorzy :
Hercun J; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Kim GE; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Da BL; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Rotman Y; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Kleiner DE; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Chang R; Clinical Center, National Institutes of Health, Bethesda, MD, USA.
Glenn JS; Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Hoofnagle JH; Liver Disease Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Koh C; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Heller T; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 176-182. Date of Electronic Publication: 2021 May 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Umbrella review of 42 systematic reviews with meta-analyses: the safety of proton pump inhibitors.
Autorzy :
Salvo EM; Value & Evidence Division, Marketing and Market Access, EVERSANA, Burlington, ON, Canada.
Ferko NC; Value & Evidence Division, Marketing and Market Access, EVERSANA, Burlington, ON, Canada.
Cash SB; Value & Evidence Division, Marketing and Market Access, EVERSANA, Burlington, ON, Canada.
Gonzalez A; Health Economics and Market Access, Ethicon Inc, Somerville, NJ, USA.
Kahrilas PJ; Feinberg School of Medicine at Northwestern University, Chicago, IL, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 129-143. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Risk of severe COVID-19 in patients treated with IBD medications: a French nationwide study.
Autorzy :
Meyer A; EPIPHARE, Épidémiologie des produits de santé, ANSM-CNAM, Saint Denis, France.; Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.; Université Paris Saclay, Le Kremlin Bicêtre, France.
Semenzato L; EPIPHARE, Épidémiologie des produits de santé, ANSM-CNAM, Saint Denis, France.
Zureik M; EPIPHARE, Épidémiologie des produits de santé, ANSM-CNAM, Saint Denis, France.; Université Versailles Saint-Quentin en Yvelines, Montigny le Bretonneux, France.
Weill A; EPIPHARE, Épidémiologie des produits de santé, ANSM-CNAM, Saint Denis, France.
Carbonnel F; Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Le Kremlin Bicêtre, France.; Université Paris Saclay, Le Kremlin Bicêtre, France.
Dray-Spira R; EPIPHARE, Épidémiologie des produits de santé, ANSM-CNAM, Saint Denis, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 160-166. Date of Electronic Publication: 2021 Jun 10.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Inflammatory Bowel Diseases*/drug therapy
Humans ; Immunologic Factors ; SARS-CoV-2 ; Tumor Necrosis Factor Inhibitors
Czasopismo naukowe
Tytuł :
Editorial: type D personality and its relationship with depression and disease activity in inflammatory bowel disease-authors' reply.
Autorzy :
Jordi SBU; Department of Gastroenterology and Hepatology, University Hospital Zurich and Zurich University, Zurich, Switzerland.; Clinic for Visceral Surgery and Medicine, Inselspital Bern and Bern University, Bern, Switzerland.
Misselwitz B; Clinic for Visceral Surgery and Medicine, Inselspital Bern and Bern University, Bern, Switzerland.
Begré S; Neurology, Department of Biomedical Research, Bern University Hospital, University of Bern, Bern, Switzerland.; ISFOM - Institute of Stress Diseases and Stress management, Zurich, Switzerland.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 82-83.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Colitis*
Inflammatory Bowel Diseases*
Type D Personality*
Depression ; Humans
Opinia redakcyjna
Tytuł :
Letter: opioid use, early biologic discontinuation for inflammatory bowel disease and a cautionary note for the age of legalised cannabis.
Autorzy :
Oseni E; Division of Medicine, Northwell Health: North Shore University Hospital and Long Island Jewish Medical Center, Manhasset, NY, USA.
Sultan K; Department of Gastroenterology, Northwell Health: North Shore University Hospital and Long Island Jewish Medical Center, Manhasset, NY, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 92-93.
Typ publikacji :
Letter; Comment
MeSH Terms :
Biological Products*
Cannabis*
Colitis*
Inflammatory Bowel Diseases*/drug therapy
Analgesics, Opioid/adverse effects ; Humans
Opinia redakcyjna
Tytuł :
Characterisation of patients with supine nighttime reflux: observations made with prolonged wireless oesophageal pH monitoring.
Autorzy :
Oude Nijhuis RAB; Department of Gastroenterology & Hepatology, Amsterdam Gastroenterology and Metabolism, University Medical Centers Amsterdam, Amsterdam, the Netherlands.
Sweis R; GI Physiology Unit, GI Services, University College London, London, UK.
Abdul-Razakq H; GI Physiology Unit, GI Services, University College London, London, UK.
Schuitenmaker JM; Department of Gastroenterology & Hepatology, Amsterdam Gastroenterology and Metabolism, University Medical Centers Amsterdam, Amsterdam, the Netherlands.
Wong T; Oesophageal Physiology Laboratory, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Rusu RI; Oesophageal Physiology Laboratory, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Oors J; Department of Gastroenterology & Hepatology, Amsterdam Gastroenterology and Metabolism, University Medical Centers Amsterdam, Amsterdam, the Netherlands.
Smout AJPM; Department of Gastroenterology & Hepatology, Amsterdam Gastroenterology and Metabolism, University Medical Centers Amsterdam, Amsterdam, the Netherlands.
Bredenoord AJ; Department of Gastroenterology & Hepatology, Amsterdam Gastroenterology and Metabolism, University Medical Centers Amsterdam, Amsterdam, the Netherlands.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 144-152. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Editorial: withdrawal of anti-TNFalpha-are we ready for biological therapy cycling? Authors' reply.
Autorzy :
Casanova MJ; Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
Chaparro M; Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
Gisbert JP; Department of Gastroenterology, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 86-87.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Colitis*
Inflammatory Bowel Diseases*
Biological Therapy ; Humans ; Longitudinal Studies
Opinia redakcyjna
Tytuł :
The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography.
Autorzy :
Ajmera V; Division of Gastroenterology, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.; Division of Gastroenterology, University of California at San Diego, La Jolla, CA, USA.
Liu A; Division of Gastroenterology, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.
Bettencourt R; Division of Gastroenterology, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.
Dhar D; Division of Gastroenterology, University of California at San Diego, La Jolla, CA, USA.
Richards L; Division of Gastroenterology, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.
Loomba R; Division of Gastroenterology, NAFLD Research Center, University of California at San Diego, La Jolla, CA, USA.; Division of Gastroenterology, University of California at San Diego, La Jolla, CA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 68-77. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Elasticity Imaging Techniques*
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Non-alcoholic Fatty Liver Disease*/genetics
Non-alcoholic Fatty Liver Disease*/pathology
Cross-Sectional Studies ; Female ; Fibrosis ; Humans ; Liver/diagnostic imaging ; Liver/pathology ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/etiology ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Role of smoking in functional dyspepsia and irritable bowel syndrome: three random population-based studies.
Autorzy :
Talley NJ; Faculty of Health and Medicine, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Australia, 2305, Australia.; NHMRC Centre for Research Excellence in Digestive Health, Australia.
Powell N; Division of Digestive Disease, Imperial College, London, UK.
Walker MM; Faculty of Health and Medicine, University of Newcastle, Lot 1 Kookaburra Circuit, New Lambton Heights, Australia, 2305, Australia.; NHMRC Centre for Research Excellence in Digestive Health, Australia.
Jones MP; NHMRC Centre for Research Excellence in Digestive Health, Australia.; Department of Psychology, Macquarie University, North Ryde, NSW, Australia.
Ronkainen J; Center for Life Course Health Research, University of Oulu, Oulu, Finland.; Primary Health Care Centre, Tornio, Finland.
Forsberg A; Department of Medicine Solna, Karolinska Institutet, Solna, Sweden.
Kjellström L; Gastromottagningen City, Stockholm, Sweden.
Hellström PM; Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
Aro P; Arokero OY, Tornio, Finland.
Wallner B; Department of Surgical and Perioperatve Sciences, Umeå University, Umeå, Sweden.
Agréus L; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Andreasson A; Department of Psychology, Macquarie University, North Ryde, NSW, Australia.; Department of Medicine Solna, Karolinska Institutet, Solna, Sweden.; Stress Research Institute, Department of Psychology, Stockholm University, Stockholm, Sweden.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 32-42. Date of Electronic Publication: 2021 May 13.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't
MeSH Terms :
Dyspepsia*/epidemiology
Dyspepsia*/etiology
Irritable Bowel Syndrome*/epidemiology
Irritable Bowel Syndrome*/etiology
Diarrhea ; Female ; Humans ; Male ; Middle Aged ; Smoking/adverse effects ; Surveys and Questionnaires ; Sweden/epidemiology
Czasopismo naukowe
Tytuł :
Review article: the evolution of endpoint assessments for chemotherapy-induced nausea and vomiting and post-operative nausea and vomiting-a perspective from the US Food and Drug Administration.
Autorzy :
Gabby ME; Division of Gastroenterology, Center for Drug Evaluation and Research, Office of New Drugs, The U.S. Food and Drug Administration, Silver Spring, MD, USA.
Bugin K; Division of Gastroenterology, Center for Drug Evaluation and Research, Office of New Drugs, The U.S. Food and Drug Administration, Silver Spring, MD, USA.
Lyons E; Division of Gastroenterology, Center for Drug Evaluation and Research, Office of New Drugs, The U.S. Food and Drug Administration, Silver Spring, MD, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 7-13. Date of Electronic Publication: 2021 May 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antiemetics*/therapeutic use
Antineoplastic Agents*/adverse effects
Adult ; Antineoplastic Combined Chemotherapy Protocols ; Child ; Humans ; Postoperative Nausea and Vomiting/chemically induced ; Postoperative Nausea and Vomiting/drug therapy ; Postoperative Nausea and Vomiting/prevention & control ; United States ; United States Food and Drug Administration ; Vomiting/chemically induced ; Vomiting/drug therapy
Czasopismo naukowe
Tytuł :
Editorial: type D personality and its relationship with depression and disease activity in inflammatory bowel disease.
Autorzy :
Knowles SR; Department of Psychology, Swinburne University of Technology, Melbourne, Vic., Australia.
Mikocka-Walus A; School of Psychology, Deakin University Geelong, Melbourne, Vic., Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 80-81.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Colitis*
Inflammatory Bowel Diseases*
Type D Personality*
Anxiety ; Depression ; Humans
Opinia redakcyjna
Tytuł :
Systematic review and meta-analysis: the incidence and prevalence of paediatric coeliac disease across Europe.
Autorzy :
Roberts SE; Swansea, UK.
Morrison-Rees S; Swansea, UK.
Thapar N; London, UK.; Brisbane, Australia.
Benninga MA; Amsterdam, The Netherlands.
Borrelli O; London, UK.
Broekaert I; Cologne, Germany.
Dolinsek J; Maribor, Slovenia.
Martin-de-Carpi J; Barcelona, Spain.
Mas E; Toulouse, France.
Miele E; Naples, Italy.
Pienar C; Timisoara, Romania.
Ribes-Koninckx C; Valencia, Spain.
Thomassen RA; Oslo, Norway.
Thomson M; Sheffield, UK.
Tzivinikos C; Dubai, UAE.
Thorne K; Swansea, UK.
John A; Swansea, UK.
Williams JG; Swansea, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 109-128. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Histological disease activity in patients with microscopic colitis is not related to clinical disease activity or long-term prognosis.
Autorzy :
Olsen LM; Roskilde, Denmark.
Engel PJH; Roskilde, Denmark.
Goudkade D; Geleen, The Netherlands.
Villanacci V; Brescia, Italy.
Thagaard J; Hoersholm, Denmark.; Lyngby, Denmark.
Walbech JS; Køge, Denmark.
Bohr J; Örebro, Sweden.
Kupcinskas J; Kaunas, Lithuania.
Verhaegh B; Maastricht, The Netherlands.
Münch A; Linköping, Sweden.
Guagnozzi D; Barcelona, Spain.
Fernández-Bañares F; Barcelona, Spain.
Munck LK; Køge, Denmark.; Copenhagen, Denmark.
Fiehn AK; Roskilde, Denmark.; Køge, Denmark.; Copenhagen, Denmark.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 43-52. Date of Electronic Publication: 2021 May 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colitis*
Colitis, Collagenous*/diagnosis
Colitis, Lymphocytic*/diagnosis
Colitis, Microscopic*/diagnosis
Humans ; Prognosis ; Prospective Studies
Czasopismo naukowe
Tytuł :
Systematic review with meta-analysis: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer.
Autorzy :
Chandrapalan S; Coventry, UK.
Bosch S; Amsterdam, The Netherlands.
Cubiella J; Ourense, Spain.
Guardiola J; L'Hospitalert de Llobregat (Barcelona), Spain.
Kimani P; Coventry, UK.
Mulder C; Amsterdam, The Netherlands.
Persaud K; Manchester, UK.
de Meij TGJ; Amsterdam, The Netherlands.
Altomare DF; Bari, Italy.
Brenner H; Heidelberg, Germany.
de Boer NKH; Amsterdam, The Netherlands.
Ricciardiello L; Bologna, Italy.
Arasaradnam RP; Coventry, UK.; Leicester, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 14-23. Date of Electronic Publication: 2021 May 18.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Colorectal Neoplasms*/diagnosis
Colorectal Neoplasms*/epidemiology
Volatile Organic Compounds*
Early Detection of Cancer ; Feces ; Humans ; Occult Blood ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Type D personality is associated with depressive symptoms and clinical activity in inflammatory bowel disease.
Autorzy :
Jordi SBU; Department of Gastroenterology and Hepatology, University Hospital Zurich and Zurich University, Zurich, Switzerland.; Clinic for Visceral Surgery and Medicine, Inselspital Bern and Bern University, Bern, Switzerland.
Botte F; Clinic for Visceral Surgery and Medicine, Inselspital Bern and Bern University, Bern, Switzerland.
Lang BM; Clinic for Transplantation Immunology and Nephrology (Swiss Transplant Cohort Study), University Hospital of Basel, Basel, Switzerland.
Greuter T; Department of Gastroenterology and Hepatology, University Hospital Zurich and Zurich University, Zurich, Switzerland.
Krupka N; Clinic for Visceral Surgery and Medicine, Inselspital Bern and Bern University, Bern, Switzerland.
Auschra B; Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Schreiner P; Department of Gastroenterology and Hepatology, University Hospital Zurich and Zurich University, Zurich, Switzerland.
Sulz MC; Department of Gastroenterology and Hepatology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Biedermann L; Department of Gastroenterology and Hepatology, University Hospital Zurich and Zurich University, Zurich, Switzerland.
von Känel R; Department of Consultation-Liaison Psychiatry and Psychosomatic Medicine, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Rogler G; Department of Gastroenterology and Hepatology, University Hospital Zurich and Zurich University, Zurich, Switzerland.
Begré S; Neurology, Department of Biomedical Research, Bern University Hospital, University of Bern, Bern, Switzerland.; ISFOM - Institute of Stress Diseases and Stress Management, Zurich, Switzerland.
Misselwitz B; Clinic for Visceral Surgery and Medicine, Inselspital Bern and Bern University, Bern, Switzerland.
Pokaż więcej
Corporate Authors :
Swiss IBD cohort study group
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 53-67. Date of Electronic Publication: 2021 May 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colitis, Ulcerative*
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/epidemiology
Type D Personality*
Anxiety/epidemiology ; Anxiety/etiology ; Cross-Sectional Studies ; Depression/epidemiology ; Depression/etiology ; Humans
Czasopismo naukowe
Tytuł :
Editorial: tobacco use in functional dyspepsia-another smoking gun? Authors' reply.
Autorzy :
Talley NJ; Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia.; NHMRC Centre of Research Excellence in Digestive Health, Newcastle, NSW, Australia.
Walker MM; Faculty of Health and Medicine, University of Newcastle, Newcastle, NSW, Australia.; NHMRC Centre of Research Excellence in Digestive Health, Newcastle, NSW, Australia.
Agreus L; Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Huddinge, Sweden.
Andreasson A; Department of Psychology, Macquarie University, North Ryde, NSW, Australia.; Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Stress Research Institute, Department of Psychology, Stockholm University, Stockholm, Sweden.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 79.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Dyspepsia*/epidemiology
Dyspepsia*/etiology
Gastritis*
Irritable Bowel Syndrome*
Humans ; Tobacco Use
Opinia redakcyjna
Tytuł :
Retrospective review of patients treated for cyclic vomiting syndrome with topiramate.
Autorzy :
Mooers H; Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Srivastava S; Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Garacci E; Center for Advancing Population Science, Medical College of Wisconsin, Milwaukee, WI, USA.
Venkatesan T; Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (2), pp. 153-159. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Letter: confounders and outcomes in studies of beta-blockers in liver disease-role of PPIs?
Autorzy :
Kilincalp S; Division of Gastroenterology/Hepatology, Department of Medicine, Sahlgrenska University Hospital/East, Gothenburg, Sweden.
Papachrysos N; Division of Gastroenterology/Hepatology, Department of Medicine, Sahlgrenska University Hospital/East, Gothenburg, Sweden.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 90.
Typ publikacji :
Letter; Comment
MeSH Terms :
Liver Diseases*/drug therapy
Proton Pump Inhibitors*/adverse effects
Adrenergic beta-Antagonists/adverse effects ; Histamine H2 Antagonists ; Hospitalization ; Humans ; Liver Cirrhosis/drug therapy
Opinia redakcyjna
Tytuł :
Editorial: withdrawal of anti TNF-alpha - are we ready for biological therapy cycling?
Autorzy :
Pugliese D; CEMAD, IBD UNIT, Unità Operativa Complessa di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
Armuzzi A; CEMAD, IBD UNIT, Unità Operativa Complessa di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.; Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 84-85.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Inflammatory Bowel Diseases*
Tumor Necrosis Factor Inhibitors*
Biological Therapy ; Humans ; Infliximab ; Tumor Necrosis Factor-alpha
Opinia redakcyjna
Tytuł :
Letter: Confounders and outcomes in studies of beta-blockers in liver disease-role of PPIs? Authors' reply.
Autorzy :
Sasso R; Digestive Disease Research Center, Medical University of South Carolina, Charleston, SC, USA.
Rockey DC; Digestive Disease Research Center, Medical University of South Carolina, Charleston, SC, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jul; Vol. 54 (1), pp. 91.
Typ publikacji :
Letter; Research Support, N.I.H., Extramural; Comment
MeSH Terms :
Digestive System Diseases*
Liver Diseases*/drug therapy
Adrenergic beta-Antagonists/adverse effects ; Hospitalization ; Humans ; Liver Cirrhosis/drug therapy
Raport
Tytuł :
One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease.
Autorzy :
Palom A; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
Sopena S; Biochemistry and Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
Riveiro-Barciela M; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
Carvalho-Gomes A; Instituto de Salud Carlos III, Madrid, Spain.; Liver Transplantation and Hepatology Unit, Hospital U. y P. La Fe, Universitat de València, Valencia, Spain.
Madejón A; Instituto de Salud Carlos III, Madrid, Spain.; Liver Unit, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
Rodriguez-Tajes S; Instituto de Salud Carlos III, Madrid, Spain.; Liver Unit, Hospital Clinic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
Roade L; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
García-Eliz M; Liver Transplantation and Hepatology Unit, Hospital U. y P. La Fe, Universitat de València, Valencia, Spain.
García-Samaniego J; Instituto de Salud Carlos III, Madrid, Spain.; Liver Unit, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
Lens S; Instituto de Salud Carlos III, Madrid, Spain.; Liver Unit, Hospital Clinic Barcelona, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.
Berenguer-Hayme M; Instituto de Salud Carlos III, Madrid, Spain.; Liver Transplantation and Hepatology Unit, Hospital U. y P. La Fe, Universitat de València, Valencia, Spain.
Rodríguez-Frías F; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Biochemistry and Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
Hernandez-Évole H; Liver Transplantation and Hepatology Unit, Hospital U. y P. La Fe, Universitat de València, Valencia, Spain.
Isabel Gil-García A; Instituto de Salud Carlos III, Madrid, Spain.; Liver Unit, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
Barreira A; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
Esteban R; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
Buti M; Liver Unit, Hospital Universitari Vall d'Hebron, Barcelona, Spain.; Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.; Instituto de Salud Carlos III, Madrid, Spain.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun 28. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Internal medicine hospitalisations and liver disease: a comparative disease burden analysis of a multicentre cohort.
Autorzy :
Roberts SB; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
Hansen BE; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
Shin S; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Abrahamyan L; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.; Toronto General Hospital Research Institute, University Health Network, Toronto, ON, Canada.
Lapointe-Shaw L; Department of Medicine, University of Toronto, Toronto, ON, Canada.; Division of General Internal Medicine, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.
Janssen HLA; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
Razak F; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Verma AA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada.; Department of Medicine, University of Toronto, Toronto, ON, Canada.
Hirschfield GM; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.; Toronto Centre for Liver Disease, Toronto General Hospital, University Health Network, Toronto, ON, Canada.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun 28. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
Autorzy :
Ribolsi M; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
Frazzoni M; Digestive Pathophysiology Unit, Baggiovara Hospital, Modena, Italy.
Marabotto E; Ospedale Policlinico San Martino, Genova, Italy.
De Carlo G; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
Ziola S; Ospedale Policlinico San Martino, Genova, Italy.
Maniero D; Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.
Balestrieri P; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
Cicala M; Department of Digestive Diseases, Campus Bio Medico University of Rome, Roma, Italy.
Savarino E; Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padova, Italy.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun 28. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Randomised clinical trial: adjunctive induction therapy with oral effervescent budesonide in newly diagnosed coeliac disease.
Autorzy :
Newnham ED; Departments of Gastroenterology and Hepatology, Eastern Health, Melbourne, Vic., Australia.
Clayton-Chubb D; Departments of Gastroenterology and Hepatology, Eastern Health, Melbourne, Vic., Australia.
Nagarethinam M; Departments of Gastroenterology and Hepatology, Eastern Health, Melbourne, Vic., Australia.
Hosking P; Pathology, Eastern Health, Box Hill, Vic., Australia.
Gibson PR; Departments of Gastroenterology and Hepatology, Eastern Health, Melbourne, Vic., Australia.; Department of Gastroenterology, Alfred Health, Melbourne, Vic., Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun 28. Date of Electronic Publication: 2021 Jun 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The impact of body mass index on efficacy and safety in the tofacitinib OCTAVE ulcerative colitis clinical programme.
Autorzy :
Farraye FA; Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, USA.
Qazi T; Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, OH, USA.
Kotze PG; IBD Outpatient Clinics, Colorectal Surgery Unit, Cajuru University Hospital, Pontifical Catholic University of Paraná (PUCPR), Curitiba, Brazil.
Moore GT; Department of Gastroenterology, Monash Health, Melbourne, Vic., Australia.; School of Clinical Sciences at Monash Health, Monash University, Melbourne, Vic., Australia.
Mundayat R; Pfizer Inc, New York, NY, USA.
Lawendy N; Pfizer Inc, Collegeville, PA, USA.
Sharma PP; Pfizer Inc, New York, NY, USA.
Judd DT; Pfizer Inc, Collegeville, PA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun 24. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Comorbidity before and after a diagnosis of inflammatory bowel disease.
Autorzy :
Bernstein CN; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada.; University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, Winnipeg, MB, Canada.
Nugent Z; University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, Winnipeg, MB, Canada.; Cancercare Manitoba, Winnipeg, MB, Canada.
Shaffer S; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada.; University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, Winnipeg, MB, Canada.
Singh H; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada.; University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, Winnipeg, MB, Canada.; Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Marrie RA; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada.; University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, Winnipeg, MB, Canada.; Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun 22. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Effect of point-of-care gastrointestinal ultrasound on decision-making and management in inflammatory bowel disease.
Autorzy :
Friedman AB; Department of Gastroenterology, Alfred Hospital and Monash University, Melbourne, Vic., Australia.
Asthana A; Department of Gastroenterology, Alfred Hospital and Monash University, Melbourne, Vic., Australia.; Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, Vic., Australia.
Knowles SR; Department of Gastroenterology, Alfred Hospital and Monash University, Melbourne, Vic., Australia.; Department of Psychology, Swinburne University of Technology, Melbourne, Vic., Australia.
Robbins A; AbbVie Pty Ltd, Mascot, NSW, Australia.
Gibson PR; Department of Gastroenterology, Alfred Hospital and Monash University, Melbourne, Vic., Australia.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun 22. Date of Electronic Publication: 2021 Jun 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Screening for compensated advanced chronic liver disease using refined Baveno VI elastography cutoffs in Asian patients with nonalcoholic fatty liver disease.
Autorzy :
Zhou YJ; Wenzhou, China.; Shanghai, China.
Gao F; Wenzhou, China.
Liu WY; Wenzhou, China.
Wong GL; Hong Kong, China.
Mahadeva S; Kuala Lumpur, Malaysia.
Raihan Nik Mustapha N; Alor Setar, Malaysia.
Wang XD; Wenzhou, China.
Chan WK; Kuala Lumpur, Malaysia.
Wong VW; Hong Kong, China.
Zheng MH; Wenzhou, China.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun 21. Date of Electronic Publication: 2021 Jun 21.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Limited long-term treatment persistence of first anti-TNF therapy in 538 patients with inflammatory bowel diseases: a 20-year real-world study.
Autorzy :
Blesl A; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
Binder L; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
Högenauer C; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.; Biotechmed, Graz, Austria.
Wenzl H; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
Borenich A; Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
Pregartner G; Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
Berghold A; Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
Mestel S; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
Kump P; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
Baumann-Durchschein F; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
Petritsch W; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Medical University of Graz, Graz, Austria.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun 20. Date of Electronic Publication: 2021 Jun 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Longitudinal follow-up study: effect of psychological co-morbidity on the prognosis of inflammatory bowel disease.
Autorzy :
Fairbrass KM; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
Gracie DJ; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
Ford AC; Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.; Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun 11. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Editorial: determining disability in inflammatory bowel disease-"See(k) and you shall find". Authors' reply.
Autorzy :
Tannoury J; Department of Gastroenterology, Henri Mondor Hospital, APHP, Paris Est-Créteil University (UPEC), Creteil, France.
Amiot A; Department of Gastroenterology, Henri Mondor Hospital, APHP, Paris Est-Créteil University (UPEC), Creteil, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (12), pp. 1323.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Colitis*
Disabled Persons*
Inflammatory Bowel Diseases*/diagnosis
Cross-Sectional Studies ; Humans
Opinia redakcyjna
Tytuł :
Comparison of short- and long-term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti-tumour necrosis factor therapy.
Autorzy :
Manlay L; Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France.
Boschetti G; Department of Gastroenterology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre Bénite, and INSERM U1111 - CIRI, Lyon, France.
Pereira B; Université Clermont Auvergne, CHU Clermont-Ferrand, DRCI, Unité de Biostatistiques, Clermont-Ferrand, France.
Flourié B; Department of Gastroenterology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre Bénite, and INSERM U1111 - CIRI, Lyon, France.
Dapoigny M; Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France.
Reymond M; Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France.
Sollelis E; Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France.
Gay C; Department of Gastroenterology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre Bénite, and INSERM U1111 - CIRI, Lyon, France.
Boube M; Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France.
Buisson A; Université Clermont Auvergne, Inserm, 3iHP, CHU Clermont-Ferrand, Service d'Hépato-Gastroentérologie, Clermont-Ferrand, France.; Inserm U1071, M2iSH, USC-INRA 2018, Université Clermont Auvergne, Clermont-Ferrand, France.
Nancey S; Department of Gastroenterology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre Bénite, and INSERM U1111 - CIRI, Lyon, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (12), pp. 1289-1299. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Journal Article
MeSH Terms :
Crohn Disease*/drug therapy
Ustekinumab*/therapeutic use
Adult ; Antibodies, Monoclonal, Humanized/therapeutic use ; Humans ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors
Czasopismo naukowe
Tytuł :
Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
Autorzy :
Liu Q; Stockholm, Sweden.
Simin J; Stockholm, Sweden.
Debelius J; Stockholm, Sweden.
Fall K; Stockholm, Sweden.; Örebro, Sweden.
Sadr-Azodi O; Stockholm, Sweden.
Engstrand L; Stockholm, Sweden.
Williams C; Stockholm, Sweden.; Stockholm, Sweden.
Brusselaers N; Stockholm, Sweden.; Antwerp, Belgium.; Ghent, Belgium.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (11), pp. 1216-1225. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Colorectal Neoplasms*/chemically induced
Colorectal Neoplasms*/epidemiology
Colorectal Neoplasms*/prevention & control
Hormone Replacement Therapy*/adverse effects
Adult ; Cohort Studies ; Estrogens/adverse effects ; Female ; Humans ; Middle Aged ; Risk Factors ; Sweden/epidemiology
Czasopismo naukowe
Tytuł :
Letter: the use of magnetic resonance scores (Anali) for risk stratification in PSC-authors' reply.
Autorzy :
Russo MW; Division of Hepatology, Carolinas Medical Center, Atrium Health, Charlotte, NC, USA.
Mazhar A; Division of Hepatology, Carolinas Medical Center, Atrium Health, Charlotte, NC, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (12), pp. 1331.
Typ publikacji :
Letter; Comment
MeSH Terms :
Cholangitis, Sclerosing*
Humans ; Magnetic Resonance Spectroscopy ; Prognosis ; Risk Assessment
Opinia redakcyjna
Tytuł :
Letter: risk of coeliac disease-do microbial-derived factors promote and protect?
Autorzy :
Sundqvist T; Division of Inflammation and Infection, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Stenhammar L; Department of Paediatrics, Department of Clinical and Experimental Medicine, Linköping University, Norrköping, Sweden.
Tjellström B; Department of Paediatrics, Department of Clinical and Experimental Medicine, Linköping University, Norrköping, Sweden.; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Magnusson KE; Division of Inflammation and Infection, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Midtvedt T; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Norin E; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Högberg L; Department of Paediatrics, Department of Clinical and Experimental Medicine, Linköping University, Norrköping, Sweden.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (12), pp. 1326-1327.
Typ publikacji :
Letter; Comment
MeSH Terms :
Celiac Disease*/epidemiology
Humans
Opinia redakcyjna
Tytuł :
Editorial: liver stiffness by magnetic resonance elastography and cardiovascular risk in non-alcoholic fatty liver disease-simply associated or more complicated?
Autorzy :
Demirtas CO; Department of Gastroenterology, School of Medicine, Marmara University, Istanbul, Turkey.
Yilmaz Y; Department of Gastroenterology, School of Medicine, Marmara University, Istanbul, Turkey.; Liver Research Unit, Institute of Gastroenterology, Marmara University, Istanbul, Turkey.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (11), pp. 1228-1229.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Cardiovascular Diseases*/diagnostic imaging
Cardiovascular Diseases*/epidemiology
Cardiovascular Diseases*/etiology
Elasticity Imaging Techniques*
Non-alcoholic Fatty Liver Disease*/complications
Non-alcoholic Fatty Liver Disease*/diagnostic imaging
Non-alcoholic Fatty Liver Disease*/pathology
Heart Disease Risk Factors ; Humans ; Liver/diagnostic imaging ; Liver/pathology ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/pathology ; Risk Factors
Opinia redakcyjna
Tytuł :
One-year outcomes with ustekinumab therapy in infliximab-refractory paediatric ulcerative colitis: a multicentre prospective study.
Autorzy :
Dhaliwal J; Division of Gastroenterology, Hepatology, and Nutrition, Department of Paediatrics and IBD Centre, SickKids Hospital, University of Toronto, Toronto, ON, Canada.; Division of Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
McKay HE; Division of Gastroenterology, Hepatology, and Nutrition, Department of Paediatrics and IBD Centre, SickKids Hospital, University of Toronto, Toronto, ON, Canada.
Deslandres C; Hopital Ste Justine, Universite de Montreal, Montreal, QC, Canada.
Debruyn J; Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada.
Wine E; Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada.
Wu A; Division of Gastroenterology, Hepatology, and Nutrition, Department of Paediatrics and IBD Centre, SickKids Hospital, University of Toronto, Toronto, ON, Canada.
Huynh H; Stollery Children's Hospital, University of Alberta, Edmonton, AB, Canada.
Carman N; Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON, Canada.
Crowley E; Faculty of Health Sciences, Western University, London, ON, Canada.
Church PC; Division of Gastroenterology, Hepatology, and Nutrition, Department of Paediatrics and IBD Centre, SickKids Hospital, University of Toronto, Toronto, ON, Canada.
Walters TD; Division of Gastroenterology, Hepatology, and Nutrition, Department of Paediatrics and IBD Centre, SickKids Hospital, University of Toronto, Toronto, ON, Canada.
Ricciuto A; Division of Gastroenterology, Hepatology, and Nutrition, Department of Paediatrics and IBD Centre, SickKids Hospital, University of Toronto, Toronto, ON, Canada.
Griffiths AM; Division of Gastroenterology, Hepatology, and Nutrition, Department of Paediatrics and IBD Centre, SickKids Hospital, University of Toronto, Toronto, ON, Canada.
Pokaż więcej
Corporate Authors :
Canadian Children IBD Network
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (12), pp. 1300-1308. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Adolescent ; Adult ; Canada ; Child ; Female ; Humans ; Infliximab/therapeutic use ; Male ; Prospective Studies ; Remission Induction ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors ; Ustekinumab/therapeutic use
SCR Disease Name :
Pediatric ulcerative colitis
Czasopismo naukowe
Tytuł :
Pretreatment non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of hepatocellular carcinoma development after sustained virologic response in HCV infection.
Autorzy :
Toyoda H; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Yasuda S; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Shiota S; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Sone Y; Department of Radiology, Ogaki Municipal Hospital, Ogaki, Japan.
Maeda A; Department of Surgery, Ogaki Municipal Hospital, Ogaki, Japan.
Kaneoka Y; Department of Surgery, Ogaki Municipal Hospital, Ogaki, Japan.
Kumada T; Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
Tanaka J; Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (12), pp. 1309-1316. Date of Electronic Publication: 2021 Apr 25.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Hepatocellular*/diagnostic imaging
Carcinoma, Hepatocellular*/epidemiology
Carcinoma, Hepatocellular*/etiology
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/complications
Hepatitis C, Chronic*/drug therapy
Liver Neoplasms*/diagnostic imaging
Liver Neoplasms*/epidemiology
Liver Neoplasms*/etiology
Antiviral Agents/therapeutic use ; Contrast Media/therapeutic use ; Gadolinium DTPA ; Humans ; Magnetic Resonance Imaging ; Sustained Virologic Response
Czasopismo naukowe
Tytuł :
Review article: immunisation against hepatitis B virus infection and the prevention of hepatocellular carcinoma.
Autorzy :
Vallet-Pichard A; Département d'Hépatologie, Université Paris Centre, Hôpital Cochin, APHP, INSERM U1223, Institut Pasteur, Paris, France.
Pol S; Département d'Hépatologie, Université Paris Centre, Hôpital Cochin, APHP, INSERM U1223, Institut Pasteur, Paris, France.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (11), pp. 1166-1182. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Carcinoma, Hepatocellular*/prevention & control
Hepatitis B*
Hepatitis B, Chronic*/complications
Hepatitis B, Chronic*/prevention & control
Liver Neoplasms*/prevention & control
Hepatitis B virus ; Humans ; Vaccination
Czasopismo naukowe
Tytuł :
Letter: enhancing training opportunities for upper GI bleeding in Sheffield - a UK transferable model? Authors' reply.
Autorzy :
Chaudhary S; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK.
Stanley AJ; Department of Gastroenterology, Glasgow Royal Infirmary, Glasgow, UK.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (11), pp. 1243.
Typ publikacji :
Letter; Comment
MeSH Terms :
Gastrointestinal Hemorrhage*/therapy
Demography ; Humans ; Scotland ; United Kingdom
Opinia redakcyjna
Tytuł :
Clinical outcome after anti-tumour necrosis factor therapy discontinuation in 1000 patients with inflammatory bowel disease: the EVODIS long-term study.
Autorzy :
Casanova MJ; Madrid, Spain.
Chaparro M; Madrid, Spain.
Nantes Ó; Pamplona, Spain.
Benítez JM; Córdoba, Spain.
Rojas-Feria M; Sevilla, Spain.
Castro-Poceiro J; Barcelona, Spain.
Huguet JM; Valencia, Spain.
Martín-Cardona A; Terrassa, Spain.
Aicart-Ramos M; Madrid, Spain.
Tosca J; Valencia, Spain.
Martín-Rodríguez MDM; Granada, Spain.
González-Muñoza C; Barcelona, Spain.
Mañosa M; Badalona, Spain.
Leo-Carnerero E; Sevilla, Spain.
Lamuela-Calvo LJ; Zaragoza, Spain.
Pérez-Martínez I; Oviedo, Spain.
Bujanda L; Donostia, Spain.
Hinojosa J; Valencia, Spain.
Pajares R; Madrid, Spain.
Argüelles-Arias F; Sevilla, Spain.
Pérez-Calle JL; Madrid, Spain.
Rodríguez-González GE; Santa Cruz de Tenerife, Spain.
Guardiola J; Barcelona, Spain.
Barreiro-de Acosta M; Santiago de Compostela, Spain.
Gisbert JP; Madrid, Spain.
Pokaż więcej
Corporate Authors :
EVODIS Study Group*
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (12), pp. 1277-1288. Date of Electronic Publication: 2021 May 07.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Colitis, Ulcerative*/drug therapy
Inflammatory Bowel Diseases*/drug therapy
Adalimumab/therapeutic use ; Humans ; Infliximab/therapeutic use ; Recurrence ; Remission Induction ; Retrospective Studies ; Treatment Outcome ; Tumor Necrosis Factor Inhibitors ; Tumor Necrosis Factor-alpha
Czasopismo naukowe
Tytuł :
Review article: the role of nutrition in alcohol-associated liver disease.
Autorzy :
Bhavsar-Burke I; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University, Indianapolis, IN, USA.
Jansson-Knodell CL; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University, Indianapolis, IN, USA.
Gilmore AC; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University, Indianapolis, IN, USA.
Crabb DW; Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University, Indianapolis, IN, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (12), pp. 1268-1276. Date of Electronic Publication: 2021 Apr 25.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Hepatic Encephalopathy*
Malnutrition*/complications
Malnutrition*/epidemiology
Humans ; Nutrition Assessment ; Nutritional Status ; Nutritional Support
Czasopismo naukowe
Tytuł :
Letter: faecal microbiota transplant in Clostridioides difficile infection: learning from the common water hyacinth.
Autorzy :
Singh AR; Department of Medicine, Base Hospital Barrackpore, Kolkata, India.
Sachan A; Department of Gastroenterology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
Shankar S; Consultant Rheumatologist and Clinical Immunologist, Army Hospital (Research & Referral), New Delhi, India.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (11), pp. 1244-1245.
Typ publikacji :
Letter; Comment
MeSH Terms :
Clostridium Infections*/therapy
Eichhornia*
Clostridioides ; Fecal Microbiota Transplantation ; Humans ; Vancomycin ; Water
Opinia redakcyjna
Tytuł :
Editorial: trends in paediatric inflammatory bowel disease attributable direct costs-authors' reply.
Autorzy :
El-Matary W; Department of Pediatrics, University of Manitoba, Winnipeg, MB, Canada.; IBD Clinical and Research Center, University of Manitoba, Winnipeg, MB, Canada.
Nugent Z; IBD Clinical and Research Center, University of Manitoba, Winnipeg, MB, Canada.; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
Witt J; Department of Economics, University of Manitoba, Winnipeg, MB, Canada.
Bernstein CN; IBD Clinical and Research Center, University of Manitoba, Winnipeg, MB, Canada.; Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (11), pp. 1234-1235.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Colitis*
Inflammatory Bowel Diseases*/epidemiology
Child ; Costs and Cost Analysis ; Humans
Opinia redakcyjna
Tytuł :
Response of eosinophilic oesophagitis to proton pump inhibitors is associated with impedance-pH parameters implying anti-reflux mechanism of action.
Autorzy :
Frazzoni M; Digestive Pathophysiology Unit and Digestive Endoscopy Unit, Baggiovara Hospital, Modena, Italy.
Frazzoni L; Gastroenterology Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
De Bortoli N; Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy.
Russo S; Digestive Pathophysiology Unit and Digestive Endoscopy Unit, Baggiovara Hospital, Modena, Italy.
Tolone S; General and Bariatric Surgery Unit, Department of Surgery, 2nd University of Napoli, Naples, Italy.
Arsiè E; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milano, Milan, Italy.
Conigliaro R; Digestive Pathophysiology Unit and Digestive Endoscopy Unit, Baggiovara Hospital, Modena, Italy.
Penagini R; Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milano, Milan, Italy.
Savarino E; Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (11), pp. 1183-1189. Date of Electronic Publication: 2021 Apr 15.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Eosinophilic Esophagitis*/drug therapy
Proton Pump Inhibitors*/therapeutic use
Electric Impedance ; Esophageal pH Monitoring ; Humans ; Hydrogen-Ion Concentration ; Prospective Studies
Czasopismo naukowe
Tytuł :
Letter: enhancing training opportunities for upper GI bleeding in Sheffield-a UK transferable model?
Autorzy :
Adu-Tei S; Royal Hallamshire Hospital, The Academic Unit of Gastroenterology, Sheffield, England.
Raju SA; Royal Hallamshire Hospital, The Academic Unit of Gastroenterology, Sheffield, England.
Marks LJS; Royal Hallamshire Hospital, The Academic Unit of Gastroenterology, Sheffield, England.
Daoub M; Royal Hallamshire Hospital, The Academic Unit of Gastroenterology, Sheffield, England.
Kakkar N; Royal Hallamshire Hospital, The Academic Unit of Gastroenterology, Sheffield, England.
Bevis EDA; Royal Hallamshire Hospital, The Academic Unit of Gastroenterology, Sheffield, England.
Shiha MG; Royal Hallamshire Hospital, The Academic Unit of Gastroenterology, Sheffield, England.
Ching HL; Royal Hallamshire Hospital, The Academic Unit of Gastroenterology, Sheffield, England.
Thoufeeq M; Royal Hallamshire Hospital, The Academic Unit of Gastroenterology, Sheffield, England.
Sanders DS; Royal Hallamshire Hospital, The Academic Unit of Gastroenterology, Sheffield, England.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (11), pp. 1241-1242.
Typ publikacji :
Letter; Comment
MeSH Terms :
Gastrointestinal Hemorrhage*/therapy
Demography ; Humans ; Risk Factors ; Scotland ; United Kingdom
Opinia redakcyjna
Tytuł :
Review article: diagnosis, management and patient perspectives of the spectrum of constipation disorders.
Autorzy :
Sharma A; Division of Gastroenterology/Hepatology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Rao SSC; Division of Gastroenterology/Hepatology, Medical College of Georgia, Augusta University, Augusta, GA, USA.
Kearns K; DuPage Medical Group, Hoffman Estates, IL, USA.
Orleck KD; Atlanta Gastroenterology, Atlanta, GA, USA.
Waldman SA; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA, USA.
Pokaż więcej
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (12), pp. 1250-1267. Date of Electronic Publication: 2021 Apr 28.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
MeSH Terms :
Constipation*/diagnosis
Constipation*/therapy
Laxatives*/therapeutic use
Biofeedback, Psychology ; Chronic Disease ; Defecation ; Humans ; Manometry
Czasopismo naukowe
Tytuł :
Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study.
Autorzy :
Lamb CA; Newcastle upon Tyne, UK.
Sebastian S; Hull, UK.
Kent AJ; London, UK.
Segal JP; London, UK.
Gonzalez HA; Hull, UK.
Brookes MJ; Wolverhampton, UK.
Mehta SJ; London, UK.
Subramanian S; Liverpool, UK.
Bhala N; Birmingham, UK.
Hicks LC; London, UK.
Conley TE; Liverpool, UK.
Patel KV; London, UK.
Walker GJ; Torquay, UK.
Kennedy NA; Exeter, UK.
Pokaż więcej
Corporate Authors :
PREPARE-IBD Study Group
Źródło :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Jun; Vol. 53 (11), pp. 1236-1240.
Typ publikacji :
Letter; Comment
MeSH Terms :
COVID-19*
Inflammatory Bowel Diseases*/complications
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/epidemiology
Cohort Studies ; Humans ; SARS-CoV-2 ; United Kingdom/epidemiology
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies